Skip to search formSkip to main contentSkip to account menu

Oncolytic Virotherapy

Known as: Virotherapy, Oncolytic, Virotherapies, Oncolytic, Oncolytic Virotherapies 
Treatment using an oncolytic virus (a virus that infects and breaks down cancer cells but not normal cells). Oncolytic virus therapy may make it… 
National Institutes of Health

Related topics

Related topics

4 relations
Biological Response Modifier TherapyOncolytic Virusesnursing therapystandards characteristics

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Review: Oncolytic virotherapy, updates and future directions
Oncolytic viruses (OVs) are viral strains that can infect and kill malignant cells while spare their normal counterparts. OVs can… 
Highly Cited
2013
Highly Cited
2013
Vesicular Stomatitis Virus as an Oncolytic Agent against Pancreatic Ductal Adenocarcinoma
Volume 86, no. 6, p. 3073–3087, 2012. In follow-up studies, we observed that PCR with a large number of primer pairs designed to… 
Review
2010
Review
2010
Gene therapy and virotherapy: novel therapeutic approaches for brain tumors.
Glioblastoma multiforme (GBM) is a deadly primary brain tumor in adults, with a median survival of ~12-18 months post-diagnosis… 
Highly Cited
2009
Highly Cited
2009
Insulin resistance is a major determinant of sustained virological response in genotype 1 chronic hepatitis C patients receiving peginterferon α‐2b plus ribavirin
Background  Cross‐sectional studies suggest insulin resistance is strongly associated with hepatic steatosis and fibrosis in… 
Highly Cited
2008
Highly Cited
2008
Oncolytic vaccinia virotherapy of anaplastic thyroid cancer in vivo.
CONTEXT Anaplastic thyroid carcinoma (ATC) is a fatal disease with a median survival of only 6 months. Novel therapies are needed… 
Highly Cited
2006
Highly Cited
2006
Immune gene-viral therapy with triplex efficacy mediated by oncolytic adenovirus carrying an interferon-gamma gene yields efficient antitumor activity in immunodeficient and immunocompetent mice.
Review
2005
Review
2005
Vaccinia virus and oncolytic virotherapy of cancer.
Vaccinia viruses possess many of the key attributes necessary for an ideal viral backbone for use in oncolytic virotherapy. These… 
Review
2005
Review
2005
Oncolytic virotherapy: approaches to tumor targeting and enhancing antitumor effects.
The application of replicating viruses for the treatment of cancers represents a novel therapy that is distinct from traditional… 
Review
2002
Review
2002
RNA viruses as virotherapy agents
RNA viruses are rapidly emerging as extraordinarily promising agents for oncolytic virotherapy. Integral to the lifecycles of all… 
Highly Cited
2001
Highly Cited
2001
Ionizing radiation does not alter the antitumor activity of herpes simplex virus vector G207 in subcutaneous tumor models of human and murine prostate cancer.
Viral gene therapy against malignant tumors holds great promise for tumors that are susceptible to the oncolytic activity of… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)